Various medicines

This tender, identified by the reference ADCM 0110/26, is for the procurement of a diverse range of medicines. The specific list of medicines required is detailed within the tender documentation, indicated by a series of numerical codes (e.g., 1026926, 1027126, etc.). This procurement is likely intended to supply various healthcare facilities, hospitals, or public health programs with essential pharmaceutical products. The tender process will involve evaluating bids from pharmaceutical suppliers based on their ability to provide medicines that meet specific quality standards, regulatory approvals, and pharmacopeial requirements. Key evaluation criteria will include product availability, delivery timelines, packaging integrity, and competitive pricing. The successful bidder(s) will be responsible for ensuring a consistent and reliable supply of the specified medications. This acquisition is critical for maintaining public health services and ensuring that patients have access to necessary treatments. The tender aims to secure cost-effective procurement while upholding the highest standards of pharmaceutical quality and safety. Further details regarding the exact specifications, quantities, and delivery schedules for each listed medicine are provided in the full tender documents.

This is a supplies contract in the health and medical services, trade and industry and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 909.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.